Literature DB >> 10667206

Bacterial toxins inhibiting or activating small GTP-binding proteins.

P Boquet1.   

Abstract

Amino acids located on the switch 1 or switch 2 domains of small GTPases of the Ras and Rho family are targets of several bacterial toxins. Exoenzyme C3 from Clostridium botulinum ADP-ribosylates specifically Rho at R43 and prevents the recruitment of Rho on the cell membrane. This blocks the downstream effects of the Rho GTPase. However, exoenzyme C3 is not a toxin, and chimeric proteins fusing C3 with the B moiety of either diphtheria toxin or Pseudomonas aeruginosa exotoxin A have been produced to intoxicate cells with low concentration of C3. C. difficile toxin B modifies by glucosylation Rho on T37 and Rac and Cdc42 on T35. Glucosylation of Rho, Rac, and Cdc42 blocks the binding of these GTPases on their downstream effectors. C. sordellii lethal toxin modifies Ras, Rap, and Rac on T35 by glucosylation. Cytotoxic necrotizing factor 1 (CNF1), from uropathogenic Escherichia coli strains, deamidates Q63 of Rho into E63, thereby blocking the intrinsic or GAP-mediated GTPase of Rho. This allows permanent activation of Rho. Thus, Rho GTPases are targets for three different toxin activities. Molecular mechanisms of these toxins are discussed.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10667206     DOI: 10.1111/j.1749-6632.1999.tb09403.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  14 in total

1.  Golgi vesicle proteins are linked to the assembly of an actin complex defined by mAbp1.

Authors:  Raymond V Fucini; Ji-Long Chen; Catherine Sharma; Michael M Kessels; Mark Stamnes
Journal:  Mol Biol Cell       Date:  2002-02       Impact factor: 4.138

2.  Mutational analysis of the enzymatic domain of Clostridium difficile toxin B reveals novel inhibitors of the wild-type toxin.

Authors:  Lea M Spyres; Jeremy Daniel; Amy Hensley; Maen Qa'Dan; William Ortiz-Leduc; Jimmy D Ballard
Journal:  Infect Immun       Date:  2003-06       Impact factor: 3.441

3.  Phosphodiesterase 4B2 gene is an effector of Toll-like receptor signaling in astrocytes.

Authors:  Elizabeth Borysiewicz; Daniel Fil; Daniel Dlaboga; James M O'Donnell; Gregory W Konat
Journal:  Metab Brain Dis       Date:  2009-09       Impact factor: 3.584

4.  Identification of Clostridium difficile toxin B cardiotoxicity using a zebrafish embryo model of intoxication.

Authors:  Elaine E Hamm; Daniel E Voth; Jimmy D Ballard
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-11       Impact factor: 11.205

5.  pH-enhanced cytopathic effects of Clostridium sordellii lethal toxin.

Authors:  M Qa'Dan; L M Spyres; J D Ballard
Journal:  Infect Immun       Date:  2001-09       Impact factor: 3.441

6.  Sphingosine-1-phosphate receptor-2 regulates expression of smooth muscle alpha-actin after arterial injury.

Authors:  Allison D Grabski; Takuya Shimizu; Jessie Deou; William M Mahoney; Michael A Reidy; Guenter Daum
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-07-16       Impact factor: 8.311

7.  Examination of signalling pathways involved in muscarinic responses in bovine ciliary muscle using YM-254890, an inhibitor of the Gq/11 protein.

Authors:  F Yasui; M Miyazu; A Yoshida; K Naruse; A Takai
Journal:  Br J Pharmacol       Date:  2008-04-21       Impact factor: 8.739

8.  Clostridium sordellii lethal toxin is maintained in a multimeric protein complex.

Authors:  Daniel E Voth; Maen Qa'Dan; Elaine E Hamm; Joy M Pelfrey; Jimmy D Ballard
Journal:  Infect Immun       Date:  2004-06       Impact factor: 3.441

9.  Degeneration and regeneration of murine skeletal neuromuscular junctions after intramuscular injection with a sublethal dose of Clostridium sordellii lethal toxin.

Authors:  Julien Barbier; Michel R Popoff; Jordi Molgó
Journal:  Infect Immun       Date:  2004-06       Impact factor: 3.441

10.  Phosphorylation of mouse immunity-related GTPase (IRG) resistance proteins is an evasion strategy for virulent Toxoplasma gondii.

Authors:  Tobias Steinfeldt; Stephanie Könen-Waisman; Lan Tong; Nikolaus Pawlowski; Tobias Lamkemeyer; L David Sibley; Julia P Hunn; Jonathan C Howard
Journal:  PLoS Biol       Date:  2010-12-21       Impact factor: 8.029

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.